SCHEMBL12901726

SCHEMBL12901726

O=C(NCCNCc1cccnc1)c1sccc1Nc1ccnc2[nH]ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNK O75909 1/20 0.37
CDK12 Q9NYV4 1/20 0.37
TYK2 P29597 3/20 0.37
JAK2 O60674 2/20 0.37
JAK1 P23458 2/20 0.37
HPGD P15428 3/20 0.36
PKM P14618 2/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 2/20 0.36
NUDT1 P36639 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
JAK3 P52333 1/20 0.36
HTT P42858 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12900662 0.92 CTDSP1 (0.40) TYK2JAK2JAK1HPGDTSHR
SCHEMBL1231271 0.92 HTT (0.44) HPGDPKMTSHRALDH1A1KDM4E
SCHEMBL12901738 0.90 KDR (0.40) TYK2JAK2JAK1ALDH1A1NAMPT
SCHEMBL12900697 0.90 HDAC2 (0.42) CCNKCDK12TYK2JAK2JAK1
SCHEMBL12901027 0.87 JAK2 (0.37) TYK2JAK2JAK1CYP1A2CYP2C19
SCHEMBL12900383 0.86 KDM4E (0.40) TYK2JAK2JAK1ALDH1A1KDM4E
SCHEMBL12900661 0.86 AKT1 (0.41) TYK2JAK2JAK1HPGDKDM4E
SCHEMBL12901718 0.86 NEK1 (0.36) TYK2JAK2JAK1NUDT1NEK1
SCHEMBL12901028 0.86 NEK1 (0.36) TYK2JAK2JAK1NUDT1NEK1
SCHEMBL12900705 0.86 ALDH1A1 (0.38) TYK2JAK2JAK1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462141-B1 NOVEL AZAHETEROCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2017-09-27 EP disclosed
US-9023847-B2 Azaheterocyclic compounds MERCK PATENT GMBH (DE) 2015-05-05 US disclosed
US-20120277228-A1 Novel Azaheterocyclic Compounds MERCK PATENT GMBH (DE) 2012-11-01 US disclosed
WO-2011017009-A1 NOVEL AZAHETEROCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277228-A1 Novel Azaheterocyclic Compounds PCNA, MCL1, MYC CCNK 18/4885CDK12 42/4885TYK2 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.